Prognostic significance of p53 overexpression in primary breast cancer; a novel luminometric immunoassay applicable on steroid receptor cytosols.

A novel quantitative luminometric immunoassay (LIA) has been developed for the measurement of wild-type and mutant p53 protein in extracts from breast tumour tissue. The LIA was found to yield reliable estimates of p53 expression in cytosol samples routinely prepared for steroid receptor analysis as...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Borg, A., Lennerstrand, J., Stenmark-Askmalm, M., Fernö, M., Brisfors, A., Ohrvik, A., Stål, O., Killander, D., Lane, D., Brundell, J.
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group 1995
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2033772/
https://ncbi.nlm.nih.gov/pubmed/7734292
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares